3-meo-pce
3-meo-pce =========
3-MeO-PCP, or 3-Methoxyphencyclidine, is a potent dissociative anesthetic categorised 3-meo-pce and 2f dck under arylcyclohexylamines. 3 MeO PCP, also referred to as 3-Methoxyphencyclidine, is a synthetic dissociative substance within the arylcyclohexylamine class. The toxicity and long-term well being results of recreational 3-MeO-PCP use has not been studied in any scientific context and the precise poisonous dosage is unknown. 3-Methoxyphencyclidine (also often known as 3-MeO-PCP) is a lesser-known novel dissociative substance of the arylcyclohexylamine class.
- It is strongly discouraged to take this substance in excessive dosages, for multiple days in a row, or together with other substances that enhance the danger of psychosis.
- All products are strictly for research purposes only and never for human consumption.
- The patient was first transferred to a psychiatric hospital after which discharged to house after a quantity of days.
- 3 MeO PCP, also referred to as 3-Methoxyphencyclidine, is a synthetic dissociative substance within the arylcyclohexylamine class.
- This product is intended strictly for laboratory analysis, including pharmacological, toxicological, and forensic studies.
Product Specs =============
3-MeO-PCP , It is structurally related to arylcyclohexylamines like PCP, MXE, and 3-MeO-PCE was first synthesized in 1979 to investigate the structure-activity relationship of phencyclidine (PCP) derivatives. In phrases of its long-term well being effects when used repeatedly and excessively for extended durations of time, 3-MeO-PCP seems to exhibit almost equivalent bladder and urinary tract problems to those discovered inside ketamine, but to a lesser extent. Due to the chance of psychosis, it isn't really helpful to combine this substance with different substances, especially stimulants, psychedelics, or other dissociatives like MXE. 3-MeO-PCP presents cross-tolerance with all dissociatives, which means that after the consumption of 3-MeO-PCP, all dissociatives could have a decreased effect. Like its sister compound PCP and unlike 3-meo-pce legal ketamine, 3-MeO-PCP exhibits a excessive affinity for inhibiting the relatively unstudied PCP2 glutamate receptor.[citation needed] A particular subtype of glutamate receptor, NMDA (N-Methyl-D-Aspartate), modulates the transmission of electrical signals between neurons in the mind and spinal cord; for the signals to move, the receptor should be open.